Keeping Track: US FDA Approves Emflaza And Parsabiv, Turns Down Opioid/Anti-Emetic Combo CL-108

 
• By Bridget Silverman and Derrick Gingery

The latest drug development news and highlights from our FDA Performance Tracker.

More from Approvals

More from Product Reviews